Insulin Pump Therapy and Continuous Glucose Monitoring

Insulin pump therapy, or continuous subcutaneous insulin infusion (CSII), has evolved from a research procedure in the 1970s to a routine form of treatment for selected people with type 1 diabetes. This book is the first to combine a detailed discussion of the evidence-base for all aspects of CSII in adults and children with a practical guide to treating people with diabetes using insulin pump therapy. It also includes a discussion on the clinical applications of continuos glucose monitoring (CGM), a technology which is increasingly being used with CSII, and best injection therapy for optimizing diabetes control. The book concludes with a look into the future with a discussion on likely developments in pump therapy and CGM in the coming years, including research into an artificial pancreas and completely non-invasive glucose sensing. The book is aimed specifically at doctors, nurses, dietitians, and other healthcare professionals involved in setting up and running an Insulin Pump Service. Several national guidelines for insulin pump therapy have recently been issued. These extend the clinical indications to new groups of patients and underline the urgent need for physicians and other healthcare professionals to update themselves about CSII and to ensure improved access to insulin to insulin pump services for all eligible patient groups. This book fills that need. The book is edited by the originator of CSII and includes chapters by a well-established team responsible for one of the largest Insulin Pump Clinics in the UK, and with additional contributions from internationally acknowledged experts in insulin pump therapy, CGM, and diabetes technology.

About the Author :
John Pickup is Professor of Diabetes and Metabolism at King's College London School of Medicine, Guy's Hospital, London, UK. He received both his DPhil and medical training at Oxford University, UK. He has a long-standing interest in the development and clinical application of novel technology for the improved management of diabetes, starting from the first development of insulin pump therapy through to in vivo glucose sensors. His current research focuses on insulin pump therapy and continuous glucose monitoring in clinical practice, developing fluorescence approaches to glucose sensing, and activation of the innate immune system and inflammation as a cause of type 2 diabetes. He has edited many previous award-winning books on diabetes, and is the recipient of several research awards, including the R D Lawrence Lectureship of the British Diabetic Association (Diabetes UK), the Gotch Prize of Oxford University, and the Boehringer Mannheim Fellowship of the Biochemical Society.